Braveheart Bio Statistics
Total Valuation
Braveheart Bio has a market cap or net worth of $1.73 billion. The enterprise value is $1.65 billion.
| Market Cap | 1.73B |
| Enterprise Value | 1.65B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Braveheart Bio has 64.17 million shares outstanding.
| Current Share Class | 64.17M |
| Shares Outstanding | 64.17M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 18.93% |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.49 |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 24.19 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.11, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.11 |
| Quick Ratio | 8.06 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -27.07% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.67M |
| Employee Count | 30 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.73 |
| Average Volume (20 Days) | 510,076 |
Short Selling Information
The latest short interest is 847,773, so 1.32% of the outstanding shares have been sold short.
| Short Interest | 847,773 |
| Short Previous Month | n/a |
| Short % of Shares Out | 1.32% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.89 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.46M |
| Pretax Income | -80.23M |
| Net Income | -80.23M |
| EBITDA | n/a |
| EBIT | -19.46M |
| Earnings Per Share (EPS) | -$2.63 |
Balance Sheet
The company has $80.58 million in cash and $667,000 in debt, with a net cash position of $79.91 million or $1.25 per share.
| Cash & Cash Equivalents | 80.58M |
| Total Debt | 667,000 |
| Net Cash | 79.91M |
| Net Cash Per Share | $1.25 |
| Equity (Book Value) | 71.49M |
| Book Value Per Share | -2.57 |
| Working Capital | 71.07M |
Cash Flow
In the last 12 months, operating cash flow was -$7.20 million and capital expenditures -$36,000, giving a free cash flow of -$7.24 million.
| Operating Cash Flow | -7.20M |
| Capital Expenditures | -36,000 |
| Depreciation & Amortization | 2,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.24M |
| FCF Per Share | -$0.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Braveheart Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -4.64% |
| FCF Yield | -0.42% |
Analyst Forecast
The average price target for Braveheart Bio is $44.33, which is 64.49% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $44.33 |
| Price Target Difference | 64.49% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |